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Inasmuch as pneumonia is a self-limited disease ending by crisis or 
lysis generally  between  the  7th  and  10th  days, 3 to  5  days are fre- 
quently afforded in which an attempt may be made to produce active 
immunity before the natural  termination  of the disease takes place. 
At the suggestion of Dr. A. R. Dochez, a study was therefore under- 
taken of the onset and rate of development of pneumococcus immunity. 
As a result of recent work in oxygen therapy, it appeared to the author 
(1) that the life of the pneumonia patient was at  times prolonged by 
the inhalation of 40 to 50 per cent oxygen, a circumstance that would 
further increase the possibilities of pneumococcus vaccine in an indi- 
vidual  case.  Any  procedure that  would initiate  an earlier  activity 
of  the  immunity  mechanism  seems  therefore  to  have  therapeutic 
possibilities.  We  wish  to  report  preliminary  animal  experiments 
that  have a  bearing on this  problem. 
Historical. 
In reviewing the subject, we shall present only such work as is concerned with 
the  demonstration  of specific immunization  to  the  pneumococcus, and  shall 
therefore omit the clinical reports of pneumococcus vaccine in the treatment of 
pneumonia  as being apart from the present  purpose.  The development of im- 
munity after introduction of pneumococcus organism has been shown by a number 
of workers.  A great variety of methods of preparation  of the organism has been 
used, employing the intact cell and extracts or solutions of the cell.  The onset of 
demonstrable immunity in the studies of different investigators has been generally 
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between the 5th and 14th day after injection.  Deviations from these results wilI 
be taken up in the individual instances.  As we are concerned particularly with 
the attempt  to secure a  vaccine that would be applicable  to the treatment  of 
pneumonia, we shall stress chiefly the development of immunity during the first 
7 days after injection. 
The first demonstration that the serum of animals injected with pneumococcus 
possessed immune properties was made in 1891 by Foa and Carbone (2), Emmerich 
andFowitzky (3), andG. and F. Klemperer (4).  Neufeld (5) (1902) employed the 
bacteria separated from broth by centrifugalization, believing that the substances 
formed in the medium during growth were harmful.  Wadsworth (6) (1912) found 
that the immunity produced by whole cultures was greater than that obtained 
by the injection of the bacteria alone.  He also employed filtrates from the culture 
material after precipitation  with ammonium sulfate.  In both instances  active 
immunity was produced in the rabbit 8 to 13 days after the injection.  In  1913 
Dochez and Gillespie (7) published their classification of pneumococci which made 
possible more specific study of individual strains.  Lister (8), employing a similar 
classification in South Africa, made an intensive study of prophylactic inoculation 
against pneumococcus infection in the rabbit and in man.  He found the factor of 
dosage was of considerable importance; doses limited to hundreds of millions of 
pneumococci were of little value, whereas 1 to 10 billion organisms administered 
intravenously both in the rabbit  and in man were effective in immunizing the 
subject. 
After three intravenous injections at weekly intervals, the rabbit was able to 
withstand a lethal dose of virulent pneumococcus culture.  4 to 5 days after  the 
first  injection,  the serum of the animal in a  few instances  showed evidence of 
agglutinins when 3  volumes of serum were used to  1 of culture.  One African 
native who received an intravenous inoculation of 10 billion the first dose, 20 billion 
the second dose, and 40 billion the third dose, showed agglutinins (with 3 volumes 
of serum) 6 days subsequent  to the first injection.  The  vaccine was  prepared 
from 18 hour blood agar cultures. 
When the vaccine was administered subcutaneously, using from 2 to 12 billion 
organisms, no agglutinins were demonstrated even after three injections.  When 
20 to 30 billion doses were administered,  agglutinins appeared 7 days after the 
second injection.  In a later article, Lister (9) took his culture from human blood 
agar slants, inoculating it into trypsinated bullock heart  broth for 8  hours,  and 
then  transferring  this  culture  into  similarly  prepared  broth  for an  incubation 
period of 6 to 7 hours.  The cocci were finally suspended in saline, heated to 60  ~ 
for 1 hour, and phenol added to a  concentration of 0.5 per cent.  Other prepara- 
tions of vaccine such as (1) the filtrate after passing broth cultures through Berke- 
feld filters,  (2)  the cocci separated from broth cultures by electrolytic methods~ 
(3) the pneumococci from 40 hours incubation in glucose broth cultures he found 
relatively inert as immunizing agents. 
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Aoki (10)), bacteria subjected to freezing (Cole  (11)),  bile extracts of pneumo- 
coccus  (Neufeld  (12),  Vetrano  (13),  Cole  (11)),  glycerol extracts  (G.  and  F. 
Klemperer  (4)),  and  cultures  precipitated  by  alcohol  and  dissolved  in  water 
(Wadsworth (6)).  In all these instances, the immunity was slight, according to 
Cole (11), and never as good as from the injection of heat-killed bacteria.  He 
found that better immunity was established in the rabbit by small daily doses than 
by larger doses at weeky intervals, agglutination (+ +  with equal parts of serum 
and culture) appearing on the 11th day after the first injection.  The serum also 
protected a mouse against 0.001 cc. of virulent pneumococcus culture. 
Wadsworth  (14)  recently  recorded  quantitatively  the  degree  of  immunity 
which he obtained with a standardized vaccine made of meat infusion broth with 
0.5 per cent glucose.  After three subcutaneous injections of Type II vaccine at 
weekly intervals, there was slight active immunity after the last injection.  Thus, 
of three mice injected with 0.00001 cc. culture, one died, and of three injected with 
0.0001 cc. culture, two died. 
Larson and Nelson (15)  reported that the addition of sodium ricinolcate to a 
virulent culture of pneumococcus so that the final dilution of the soap is 0.1  per 
cent caused the organisms to lose their  pathogenicity.  When  10 cc. of such a 
culture  were injected intravenously into a  rabbit,  large  amounts of agglutinins 
were present in the blood stream 24 hours after.  Cecil (16) has produced active 
immunity in monkeys after three subcutaneous injections of Pneumococcus Types 
I and II and to a less extent in Type III.  After a single large subcutaneous injec- 
tion in man of 8 billion each of the three types, agglutination (+ in 1-1 dilution) 
was observed in some instances 7 days after.  The vaccine was made by growing 
the organisms in 0.5 per cent glucose broth for 12 to 14 hours.  Mackenzie (17) 
found that an intraperitoneal injection of 0.25 cc. of a heat-killed 18 hour culture 
produced active and passive immunity in guinea  pigs 6  days after the injection 
although  no  agglutinins  were  demonstrable.  Perlzweig  (18)  noted  active  im- 
munity  10 days after  a  single subcutaneous injection of Pneumococcus Type I 
in mice.  He also immunized mice actively with the protein fraction obtained by 
treating pneumococci with anhydrous sodium sulfate and by solution of pneumo- 
cocci in  bile  salts and  precipitation with alcohol.  Ferry and Fisher  (19)  found 
that the centHfugate from broth cultures or saline suspensions of pneumococcus 
were more effective as an immunizing agent than the sedimented bacteria.  White 
mice who were given two doses of 0.5 cc. of these extracts subcutaneously at weekly 
intervals were immune against 0.001 cc. of culture 1 week after the last injection. 
Wright (20) found that immunized rabbits cleared the blood of injected virulent 
pneumococci more effectively than normal rabbits.  This increased resistance to 
septicemia was observed as early as the 3rd day following a  single intravenous 
injection of heat-killed bacteria.  Armstrong (21) has reported passive immunity 
in rabbits and active immunity in mice both beginning on the 4th day (occasionally 
on the 3rd day) and increasing to the 6th day after injection of killed pneumococcus 
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In 1917 Dochez and Avery (22) pointed out that the pneumococcus elaborates 
a soluble specific substance which is found in the broth culture of the organism 
and  frequently in  the body fluids  of the host  as well.  Recently, Avery and 
Heidelberger (23) have separated the constituents of the pneumococcus  cell into 
two chemically and immunologicaUy distinct substances, one protein and the other 
carbohydrate.  The protein fraction is less specific than the intact bacterial cell, 
creating antibodies for the protein common to all groups of pneumococci when 
injected into animals.  The carbohydrate, which has been shown to be of poly- 
saccharide nature, is highly and specifically reactive only with the antibacterial 
serum of the same type of pneumococcus  as that from which  the substance is 
derived.  However, when dissociated  from combination with other cell elements, 
it is incapable of inducing antibody formation.  They state that solutions and 
extracts of pneumococci  behave as solutions of pneumococcus protein, i.e., produce 
antibodies reactive only with the protein.  Sera prepared from filtered solutions 
of disintegrated cells free from formed elements fail to exhibit any of the dominant 
type-specific  properties which  characterize sera obtained by immunization with 
whole bacteria.  Schiemann and Casper (24) very recently reported that a specific 
soluble substance which they made employing a technique similar to Avery and 
Heidelberger was antigenic. 
The  literature  recited  above  presents  considerable  divergence  of 
opinion in  regard  to  various  problems  in  pneumococcus  immunity. 
Our experiments have mainly emphasized two  factors:  (1)  the onset 
and  rate  of  development of pneumococcus  immunity,  (2)  the  char- 
acter  of  immunity  produced  by  the  use  of  the  intact  organism  as 
compared with that produced by a  solution or extract from the bac- 
terial cell. 
Methods. 
Numerous  experiments have  been  conducted in the  effort to  pre- 
pare  an  antigen  which  would  be  particularly effective in  producing 
early immunity.  The  detail of these  findings  will  be  considered at 
a  later date.  A  fact originally mentioned by Neufeldt was suggested 
by our  experience,  namely,  that  the  highly  virulent  organism  pro- 
vokes a  more marked immunity than an organism of low virulence. 
We  have  attempted  to  prepare  our  antigen  from  a  pneumococcus 
culture  that  was  fatal  to  a  mouse  in  10-7  dilution,  and  preferably 
passed through a  mouse immediately before using. 
Human serum was employed in a concentration of 2.5 per cent in beef infusion 
broth in order to preserve virulence to the last stage and in order to augment ALVAIW L.  BARACH  87 
growth.  The addition of glucose for stimulating growth did not  appear to be 
satisfactory because of the  readiness with  which  the  organism was  altered by 
growth in the culture medium.  Young cultures were employed also with the idea 
of preventing autolysis.  The incubation period was varied between 6 and 11 hours 
without  appreciably influencing this factor. 
Four  different  antigens  were  prepared in  the  following manner:  A  virulent 
Pneumococcus Type II  (or Type I)  culture was  passed through  a  mouse in a 
preparation of the vaccine.  0.2 cc. of the heart's blood obtained from the animal 
immediately after death was inoculated into a  test-tube containing 5 cc.  of beef 
infusion broth with 2.5 per cent of human serum.  After 8 hours incubation, this 
was used to inoculate flasks containing 250 cc. of similarly prepared broth, in the 
proportion of 0.1 cc. inoculum to 5 cc. broth.  Incubation was carried on for 8 to 11 
hours as was desired.  The culture was then centrifuged, the supernatant broth 
poured off  and saved.  Care was  taken not  to  loosen the sedimented bacteria 
at the bottom of the centrifuge tube which was now carefully rinsed with distilled 
water to wash off all broth adhering to it.  Distilled water was finally added to 
dilute the bacteria to a  concentration of  1 billion organisms to  1  ce.  of water. 
(A nephelometer was used and checked by the Wright counting method.)  The 
vaccine was sterilized by exposure to 60  ° for 1 hour.  After it had cooled, tricresol 
was added to a concentration of 0.3 per cent.  This is called in the text the 8 or the 
11 hour serum vaccine. 
The superuatant broth saved from the original culture was passed through a 
Berkefeld candle, bottled, and placed in the ice box.  The preservative was added 
after culture had demonstrated no organisms had passed through the filter.  This 
is called the broth filtrate. 
A second lot of serum vaccine before sterilizing is shaken by hand for 5 minutes 
and  centrifuged.  The  supernatant  fluid  is  passed  through  a  Berkefeld filter, 
bottled, and placed in the ice box.  If sterile on culture, the preservative is added. 
This is called the filtrate of the shaken bacteria.  The sediment remaining from 
the above is taken up in distilled water, heated for 1 hour at 60  °, and allowed to 
cool before the addition of tricresoh  This is called the washed bacteria vaccine. 
Experiments. 
Experir~n~ 1.--A series  of  white  mice  were  injected  intraperitoneally with 
three different antigens derived from Pneumococcus Type II: 0) 11 hour serum 
vaccine, (2) Berkefeld filtrate  of  shaken bacteria, (3)  washed bacteria vaccine. 
Each antigen was injected into five mice daily for 5 days.  The dose of the serum 
vaccine and  the  washed bacteria vaccine was 0.2 cc.,  representing 200  million 
organisms.  The  dose of the  filtrate was 0.4  cc.,  derived from 400  million or- 
ganisms.  At the end of the 5th day, all mice received an intraperitoneal injection 
of Type II culture in varying dilutions, as shown in Table  I.  The  test  culture 
was fatal to  a  mouse  in  10--7 dilution. 88  PNEUMOCOCCUS  VACCINE.  I 
TABLE  I. 
Active Immunity  in Mice after Intraperitoneal  Injection  of (1)  11 Hour  Serum 
Vaccine, (2) Berkefeld Filtrate of Shaken Bacteria, (3) 
Washed Bacteria Vaccine. 
Survival after 
Day  Pneumococcus  II injection 
after  of culture  Remarks  Antigen used  and dose  vacci- 
nation 
.0001  .00001  .000001 
Vaccine 0.2 cc.  1st  24  28  30 
24 
2nd  36  36  36 
36  S 
3rd  42  S  S 
42  S 
4th  60  S  6O 
S  S 
5th  S  S  68 
S  S 
Filtrate of bacteria 0.4  1st  24  28  S 
cc.  28  30 
2nd  40  40 
40 
3rd  42  40  40 
40  43 
4th  S  S  S 
S  S 
5th  S  S 
S  S  68 
Washed bacteria 0.2 cc  1st  24  28  30 
28  S 
2nd  36  40  40 
40  40 
3rd  42  40  40 
40  43 
4th  S  62  62 
S  S 
5th  S  S  S 
Controls  .01  .001  .0001 
15  15  25 
All  injections were  administered 
intraperitoneally;  antigen  and 
test culture 
The  surviving  mice were  subse- 
quently  injected with  virulent 
Type  I  culture  in  correspond- 
ing  doses.  All  died  (within 
the  same  period  that  control 
mice died) 
All antigens were  prepared  from 
an  11  hr.  Pneumococcus 
Type II culture 
.00001  .000001  .0000001 
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As noted in Table I no protection was evidenced in any of the vac- 
cinated animals on the 1st and 2nd days.  Immunity began on the 
3rd day in the case of the animals who received the serum vaccine 
and on the 4th day in those who received the washed bacteria vaccine 
and the filtrate of the shaken bacteria.  The immunity was furthez 
increased on the 5th day.  The mice who survived from this experi 
ment were injected with a  virulent Type I  culture in corresponding 
doses to the Type II culture.  All died. 
Active immunity is therefore demonstrated on the 3rd day after 
injection of the serum vaccine, and on the 4th day in the case of the 
TABLE  II. 
Active Immunity in Mice after Injection of 8 Hour Serum Vaccine. 
Antigen used and dose 
Pneumococcus  II  8  hr. 
serum vaccine 400 mil- 
lion  organisms 
Controls ... 
Day 
after 
vacci- 
nation 
1st 
2rid 
3rd 
4th 
5th 
6th 
7th 
Survival  after injection  of 
Pneurnecoccus n  culture 
40  40  60  60 
60  40  40  24 
S  S  9O 
S  S  S 
S  S  S 
40  S  S  21 
S  40  S  S 
40  21  40  96 
Remarks 
Vaccine  and  test  cul- 
ture administered in- 
traperitoneally 
washed bacteria vaccine and the filtrate of the shaken bacteria.  It is 
progressive in degree and specific for type.  The failure of any of the 
vaccinated animals to survive an injection of Type I culture indicates 
that the protection against Type II culture was not due to increase in 
general resistance but  rather to  type-specific immunity.  This  was 
produced both by the use of the intact cell and by the water-soluble 
specific substance shaken off the bacteria. 
Experiment 2.--(Table  II.)  An 8  hour  serum  vaccine was  injected daily for 
7 days into a  series of white mice, four mice to each day.  The dose was 0.4 cc., 
representing  400  million  organisms,  administered  intraperitoneaUy.  The  test 
culture was of moderate virulence, 10-6 cc. being fatal to a mouse. 90  PNEUMOCOCCUS VACCINE.  I 
As shown in Table II, immunity is present from the 3rd to the 7th 
days inclusive. 
Experiment 3.--(Table 111.)  An 8 hour serum vaccine was injected daily for 5 
days into a  series of white mice, five mice to each day.  The dose was 0.2 cc., 
TABLE  III. 
A ctive Immunity in Mice after Intraperitoneal Injection  of 8 Hour Serum Vaccine. 
Test Culture of Low Virulence. 
Antigen used and dose 
Pneumococcus II 8 hr. 
serum  vaccine  I00 
million organisms 
Controls. 
ta 
~.o 
2nd 
3rd 
4th 
5th 
Survival after injection of 
Pneumococcus  n  culture 
S  S  S  S 
S  S  S  S 
S  S  S  S 
S  S  S  S 
36  22  36  130 
S 
S 
S 
S 
Remarks 
Pneumococcus  culture  ot 
relatively low virulence 
10-6 surviving and 10-5 
fatal in 130 hrs. 
TABLE  IV. 
Active Immunity in Mice after Intraperitoneal Injection of g Hour  Serum  Vaccine. 
Test Culture of High Virulence. 
Antigen used and dose 
Pneumococcus H 8 hr. 
serum  vaccine  200 
million organisms 
Controls.. 
Day 
after 
vacci- 
nation 
1st 
2nd 
3rd 
4th 
5th 
Survival after injection of 
Pneumococcus II culture 
.001  .0001  .00001 .000001 
14  44  44  44 
20  20  20  44 
44  44  20  44 
20  53  S  S 
53  S  S  20 
14  14  20  20 
Remarks 
Pneumococcus culture  at 
maximum  virulence 
fatal in 10-7 cc. 
representing 200 million organisms.  The test culture was of low virulence, 10-5 
ce. being fatal in 130 hours.  Immunity was demonstrated from the 2nd to the 
5th day inclusive. 
Experff~nt 4.--(Table IV.)  A similar experiment to the above was performed, 
employing however, a highly virulent test culture, 10-7 cc. being fatal to a mouse. 
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TABLE  V. 
Passive Immunity  in Rabbits  after Intravenous  Injection  of (1)  Serum  Vaccine, 
(2) Berkefeld Filtrate of Shaken Bacteria, (3) Washed Bacteria 
Vaccine, (4) Berkefeld Filtrate of.Broth Culture. 
;urvival  after Survival  after 
injection  of  injection  of 
Pneumo-  Pneumo- 
Day  coccus  II  coccus  I 
after  culture  culture  Antigen  used and dose  vaccina-  Remarks 
tion 
Rabbit 4  pneumococcus 
II 11 hr. serum vaccine 
5 billion organisms 
Rabbit 7 pneumococcus 
Ii  filtrate  of shaken 
bacteria  8  cc. 
Rabbit  5  pneumococcus 
II washed bacteria vac- 
cine 5 billion  organisms 
3rd  S  60  S 
S  S  45  45 
5th  S  S  S  45  45 
S  S 
7th  S  S  S 
S  S 
9th  S  42  S 
42  S 
15th  S  S  S 
S  S 
20th  42  S  S 
S  S 
18  45  45  Mice employed in Pneumo- 
coccus  I  infections  were 
used  previously in Pneu- 
mococcus  II  experiments 
in which they survived in- 
jections of virulent Pneu- 
mococcus II culture 
All  rabbit  injections  given 
intravenously 
3rd  42  42  42 
42  6G 
4th  42  42  42i 
6C  48 
5th  S  S  S  42  45  45 
S  S  45  45 
6th  S  S  S  45  45  45 
S  S  45  45 
8th  S  S  S 
S  S 
llth  S  S  S 
S  42 
Concentration of antigens-- 
1  billion  organisms  to  1 
cc. distilled water 
3rd  S  42  S  45  45  45 
S  S i  45  45 
5th  S  S  S  45  45  45 
S  S  45  45 
7th  S  S  S 
S 13C 
9th  S  S  Sl 
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TABLE  V--Concluded. 
Antigen  used  and dose 
Rabbit 6  Pneumococcus 
II filtrate of broth cul- 
ture 10 cc. 
Day 
after 
vaccina- 
tion 
~urvlvaf after Survival  after 
injection  of  injection  d 
Pneumo-  Pneumo- 
coccus  II  coccus  I 
culture  culture 
3rd  3d  S  60 
S  60 
4th  36  42  36 
6(  S 
5th  S  ~  S 
S 
7th  S  S  S 
S  S 
15th  S  S  S 
S  S 
20th  S  S  S 
llC  S 
Rabbit serum  Before  42  42  42 
Controls Pneumococcus II~  42  42 
Controls  Pneumococcus IIf  24  24  24 
Controls Pneumococcus  I  48  48  60 
Remarks 
The  foregoing experiments  indicate that  the  onset of active im- 
munity alters with the virulence of the test culture, appearing on the 
2nd day after vaccination when an organism of low virulence is used, 
on the 4th day with an organism of very high virulence, and on the 
3rd day with an organism of moderately high virulence.  Varying the 
virulence of the organism represents the progressive increase in active 
immunity from the 2nd to the 5th day better than varying the num- 
ber  of organisms injected, for a  highly virulent culture may cause 
death of all the animals even in high di]utions and a culture of low viru- 
lence may result in complete survival.  This is in accordance with the 
results of Neill  and  Gaspari  (28)  who  found that within a  certain 
range  (10-6 to  10-3  cc. of culture) the number of invading bacteria 
was without influence in determining the occurrence of infection and 
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Experiment  5.--(Table  V.)  Four  antigens  were  used  in  this  experiment: 
(1)  11  hour serum vaccine,  (2)  filtrate of shaken bacteria, (3)  washed bacteria 
vaccine,  (4)  filtrate of broth  culture.  The dose of the  serum vaccine and the 
washed bacteria vaccine was 5 billion organisms, the  filtrate of the broth and the 
shaken bacteria was in each case derived from 10 billion organisms.  Each antigen 
was administered intravenously to a rabbit, and blood taken, before and fromthe 
3rd to the 9th day or longer.  The mouse protection test was carried out according 
to the technique of Dochez (25).  Thus, 0.2  cc. of rabbit serum was mixed with 
TABLE VI. 
Passive Immunity in Rabbits after Injection of (1) Serum Vaccine and (2) Berkefeld 
Filtrate of Shaken Bacteria. 
Antigen used and  dose 
Rabbit  3  Pneumococcus  II 
serum vaccine  2 billion 
organisms 
Rabbit 1 PneumococcusII 
serum vaccine 2 billion 
orgallisms 
Rabbit 2 Pneumococcus II 
filtrate of  shaken  bac- 
teria 2 cc. 
Day 
after 
vacci- 
[ nation 
1st 
2nd 
3rd 
4th 
5th 
6th 
7th 
3rd 
4th 
5th 
4th 
5th 
2ontrols. 
Survival after injection of 
Pneumococcus II culture 
.01  .001  .0001  !.00001 
17  64  64  64 
30  30  30  64 
30  S  S  S 
S  S  S  S 
50  30  S  S 
17  S  S  S 
S  S  S  S 
54  64  S  S 
3O  S  S  S 
46  S  S  S 
72  S  S  S 
S  S  S  S 
30  22  36  130 
Remarks 
All  antigens  admin. 
istered  intravenous- 
ly.  Vaccine and fil- 
trate  made  from  8 
hr.  serum  broth 
culture 
varying dilutions of culture and  injected intraperitoneally into mice.  Survival 
in these as in the previous active immunity experiments is recorded when the mouse 
lives 6 days after injection.  The blood drawn on the 3rd, 5th, and 6th days was 
also mixed with varying dilutions of Type I  culture to determine whether the early 
immunity secured was a general non-specific increase in natural resistance or was 
entirely due  to  the  development of Pneumococcus  Type II specific protective 
substance.  The test culture was of moderately high virulence, 10-6 cc. killing 
control animals as well as animals who received the serum of normal rabbits (i.e., 
before their vaccination with pneumococcus antigen.) 94:  PNE~OCOCCUS  VACCINE.  I 
As Table  V  indicates,  the onset of passive immunity  was  on  the 
3rd  day in  the  case of the  serum vaccine  and  the  washed  bacteria 
vaccine.  The  broth  filtrate  and  the  filtrate  of the  shaken  bacteria 
show a  definite immunity on the 5th day.  The immunity persists  as 
long  as observations  in  the  experiments  were  conducted,  from  the 
llth  to the 20th day after injection.  In a  similar experiment noted 
in Table VI, the serum vaccine initiates passive protection on the 3rd 
day also, but the filtrate of the shaken bacteria produces  an immune 
response on the 4th day.  The rabbit sera of the animals whose blood 
protected  against  Type  II  culture  failed  to  show  any  protection 
TABLE  Vll. 
Passive Immunity in Rabbit after Intravenous Injection  of Serum Vaccine. 
Antigen  used and dose 
Rabbit  I  Pncumococcus 
II 8 hr. serum vac- 
cine 2 billion  organ- 
isms 
~mnune serum 
Day 
after 
vacci- 
nation 
2nd 
3rd 
4th 
5th 
6th 
Controls... 
Survival after injection  of 
Pneumococcus  II culture 
19  19  48  48 
19  22  48  19 
19  48  48  49 
48  48  48  22 
19  48  72  72 
S  S  19  S 
22  48  48  72 
Remarks 
Virulence of pneumococ- 
cus  culture  was  at  its 
maximum, fatal in 10-7 
CO. 
Mouse with immune horse 
serum was not protected 
against 10-6 culture. 
against  Type  I  culture,  demonstrating  that  the  passive  immunity 
produced  was specific for type and  not dependent  upon increase  of 
general  resistance  or  on  the  common  protein  antibody. 
Experiment  7.--(Table VII.)  An 8 hour  serum vaccine was injected  intra- 
venously to a rabbit, and blood drawn from the 2nd to the 6th  day inclusive. 
The dose was 2 billion organisms.  The test culture was at maximum virulence, 
10-7 cc. being regularly fatal. 
No  animals  survived  in  this  experiment.  The  blood  of  rabbits 
varies  to  an  extent  in  its  power to  elaborate  protective  substance, 
particularly in the case of a  culture of maximum virulence. ALVAN  L.  BARACH  95 
Experiment &--(Table VIII.)  A series of mice were inoculated intraperiton- 
eally with an 11 hour (1) serum vaccine Type I  pneumococcus and (2)~filtrate  of 
the shaken bacteria.  The dose of the vaccine was 0.2 cc., representing 200 million 
organisms, and of the filtrate 0.4 cc., representing 400 million organisms.  The 
test culture was of very high virulence, 10-7 cc. being fatal to a mouse. 
Active immunity  began  on the  4th  day in  the  animals  vaccinated 
with  the  serum  vaccine,  and  on the  3th  day with  the  animals  vacci- 
nated  with  the  filtrate  of the  shaken  bacteria.  This  indicates  again 
that the use of a  test culture of very high virulence records the onset 
TABLE VIII. 
Active Immuni~ Following  Inlrap~itoneal I~ection ~  Type I  V~dne. 
Antigen  used and dose 
Pneumococcus  I  11  hr. 
serum  vaccine  400 mil- 
ton organisms 
Day 
after 
vacci- 
nation 
1st 
2rid 
3rd 
4th 
5th 
Controls ..... 
Survival after  injection  of 
Pneumococcus  I culture 
.ool  .oooJ  .ooooo1 
20  20  24 
20  36 
20  20  24 
35  36  36 
24  36  36 
36  36 
36  S  S 
S  48 
S  S  S 
S  48 
20  24  36 
20  24 
Remarks 
Vaccine and test  culture  ad- 
ministered  intraperiton- 
ealiy 
of  immunity  at  a  later  date  than  one  of lesser  virulence,  and  thus 
registers  the  progressive  increase  in  antibody response  from the  3rd 
to the 5th day. 
Experirae~L9.--(TablelX.)  In this experiment two antigens from  Pneumococcus 
TypeI were employed, (1) the Berkdeld filtrate of the shaken bacteria and (2) the 
filtrate of the broth culture.  A comparison was made between the standard dose and 
a very large dose.  A series of mice were inoculated intraperitoneally with 0.4 cc. 
of broth filtrate, a  second series with 1.0 cc. of broth filtrate, a  third series with 
0.2 cc. of the filtrate from the shaken bacteria, and a  fourth with 1.0 cc. of the 
filtrate of the shaken bacteria.  Each antigen was injected daily into eight mice, 
and on the 7th day after the first injection, the test culture was administered to the 96  Pl,  mtr~ococcus  VACCINE.  I 
entire series, comprising mice injected 2 to 7 days after inoculation with antigen. 
The test culture was of high virulence, 10-7 being fatal to a  mouse in 60 hours. 
As will be seen in Table IX, all the mice injected on the 2nd day 
after vaccination died,  32  in number.  Survival began on the  3rd 
day after injection in each series but usually in only one out of eight 
animals.  In the case of the filtrate of the shaken bacteria, definite 
protection was present on the 4th day, increasing to its height on the 
TABLE  IX. 
Effect  of Variation in Dosage of Antigen  on Active Immunity in Mice after Intra- 
peritoneal Injection of (1) Berkefeld Filtrate of Shaken Bacteria, 
(2) Berkefeld Filtrate of Broth Culture. 
Antigen  used  and  Remarks 
dose 
] roth filtrate 0.4 '  An injections administered 
cc.  intraperitoneally.  Fil- 
trates made from 11 hr. 
serum  vaccine,  Pneu- 
mococcus Type I. 
± 
"~  Survival~after  i~ection  of  Pneum~occ~  I 
~  c~t~e 
N.~ 
2nd  40  40  40  58 
40  58  58  $8 
3~  58  58  58  40 
58  58  58  S 
4th  18  40  58  58 
58  58  58  S 
5~  40  40  88  40 
58  58  S  S 
6th  40  40  58 
40  80  S  S 
7th  40  S  58  S 
40  S  S  S 
Broth filtrate 1.0 
CC. 
2nd  40  40  40 
4O  58  58  58 
3rd  40  40  40  40 
40  40  S  58 
4th  40  40  58  S 
58  S  58  S 
5ill  40  40  40  S 
58  40  58  80 
6th  40  48  58  S 
40  58 
7th  40  58  S  S 
40  S  S  S ALVAN  L. BARACH 
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Antigen used and 
dose  ,~  ,~.~ 
Survival after injection of Pneumococcus  I 
culture 
Bacterial filtrate  2nd  18  40  40  58 
0.2 cc.  40  40  40  58 
3rd  40  40  40  40 
4O  S  40 
4th  40  40  40  S 
40  40  S  S 
5th  18  S  S  S 
t  4o  80  s  s 
6th  40  58  80  S 
S 
7th  40  S  S  18 
40  s  18 
Bacterial filtrate  2nd  40  40  40  58 
1.0 cc.  40  40  58  58 
3rd  40  40  S 
40  i  40  4O 
4th  40  40 
40  80  S  S 
5th  40  18  S  S 
40  S  S  S 
6th  40  40  S  S 
58  58 
7th  40  58  40  S 
40  58  58 
Controls  ....  40  40  58  58 
40  40  58 
58  60 
Remarks 
5th  day,  and  remaining  approximately  stationary  to  the  7th.  In 
fact, in  this  experiment there  was a  slight falling off in survival from 
the 5th to the 7th day.  The increased dose  (1.0  cc. of filtrate)  gave 
slightly inferior results than the standard dose (0.2  cc.). 
The immunity resulting from the standard broth dose (0.4 cc.) was 
less marked than that from the filtrate  of the shaken bacteria.  Ani- 
mals survived from the  3rd to the 6th day in small numbers  and on 
the 7th day, five out of eight survived.  The large dose of broth  (1.0 
cc.)  gave a  less marked immunity response but here too,  five out of TABLE  X. 
Effect of Variation in Dosage of Antigen  on Active Immunity in Mice after Intra- 
peritoneal Injection of Serum  Vaccine. 
Day  Survival after injection of 
Antigen used and  after  Pncumococcus  I culture  Remarks  dose  vacci- 
nation  .001  .0001  .00001 
2nd  44  44  70 
44  44  70 
44  44  44 
3rd  92  92  SS 
SS  SS  S 
4th  SS  SS  SS 
S  S  S 
5th  SS  SS  SS 
S  S  S 
Serum  vaccine 
dose 0.2 cc. 
All  injections  administered  intraped- 
toneally 
Vaccine grown for 8 hrs. in 2.5 per cent 
serum broth 
Numbers  in  table  refer  to  length of 
time  in hrs. which  mice  lived  after 
injection.  S  indicates  survival  for 
6 days or more 
Dose 0.02 cc.  2nd 
3rd 
4th 
5th 
44  44  44 
44  44  44 
44 
44  44  44 
44  44 
S  S  SS 
SS  92  SS 
S  SS  S 
92  SS  SS 
SS  S  S 
Dose 0.002 cc.  2nd  44  44  44 
44  44  44 
44  44  44 
3rd  SS  44  SS 
92 
S  S  S 
4th  SS  SS  SS 
S  S  S 
5th  SS  SS  SS 
S  44  S 
Dose  0.0002  cc. 
Normal controls. 
2nd  44  44  44 
44  44  44 
44  44  44 
3rd  44  SS  44 
44  44 
S  S  S 
4th  SS  44  92 
S  SS  SS 
5th  44  70  92 
92 
S  SS  SS 
.001  .0001,0000: 
44  44  4,  44 
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eight  survived on the  7th  day.  It is observed that  in only one in- 
stance  (1  of 192  mice),  did  an animal resist 0.01  cc. of test  culture. 
On the 5th day, however, the filtrate of the shaken bacteria produced 
an immunity sufficient to withstand an injection of 0.001 cc. of a  cul- 
ture with  a  virulence of  10-' 
Experiment IO.--A series of mice were injected intraperitoneally  with the follow- 
ing doses of Type I vaccine; (1) 0.2 cc.,  (2) 0.02 cc., (3) 0.002 cc., (4) 0.0002 cc. 
TABLE  XI. 
Active  Immunity after Intraperitoneal  Injection of Pneumococcus Type I  Culture 
to Which Sodium Ricinoleate Had Been Added. 
Day  , Survival  after injection of 
after  Pneumococcus  I culture 
Antigen used and dose  vacci- 
nation  ~  .001  .0001  .00001 
).I per cent sodium  Ist  44  20  44 
ricinoleate Pneumo-  44  44  44 
coccus Type I  cul-  2nd  44  44  44 
ture  44  44  44 
3rd  44  20  44 
44  44  84 
4th  44  44  S 
S  44  S 
Dose 0A cc.  6th  S  S  S 
S  S  S 
7th  44  44 
S  S  S 
Dose  0.04  cc.  Ist  20  20  20 
20  20  20 
4th  44  44  S 
64  64  S 
Normal controls... 
Remarks 
11  hr.  Pneumococcus Type  l 
broth  culture exposed  to  a 
final concentration of  0.1  pel 
cent  sodium ricinoleate before 
injection 
El 
.001  .0001.00001 .000001~.0000(X)I[  .00000001 
44  44  44  44 [  441  44 
1 cc. of the vaccine contained 5 billion organisms.  Twelve mice were inoculated 
daffy with each antigen,  and on the 5th day a test culture of Pneulnococcus Type 
I  was  injected  intraperitoneally  into  the  entire  group.  The virulence  of the 
culture was such that 10  -9 cc. was fatal to a control animal. 
As seen in Table X  all the 2nd day mice (48 in number)  as well as 
all the control animals died.  Survival began on the 3rd day and was 100  PNEUMOCOCCUS VACCINE.  I 
more complete on the 4th and 5th days.  The immunity produced was 
fairly  constant in  the  range  of  dosage between 0.2  cc.  and 0.002 
cc., but began to diminish  when the dose of vaccine was lowered to 
0.0002  cc.  The degree of protection  on the  3rd  day was  sufficient 
to protect against t00,000 minimal lethal doses.  (When the maximal 
virulence of the organism 10 -~ is used in the calculations, the protec- 
tion is  equivalent to  1 million  minimal lethal  doses.)  The Type I 
organism produces a more marked early immunity than the Type II. 
Experimentll.--(TableXI.)  The antigen  used in this experiment was a virulent 
Type I culture exposed to a final concentration of 0.1 per cent sodium ricinoleate. 
Mice  were  inoculated with this culture intraperitoneaUy  daily for 5 days, dose 0.2 cc. 
On the 5th day a virulent test culture was injected intraperitoneally. 
Survival began on the 4th day, and was complete on the 6th.  The 
use of sodium ricinoleate did not hasten the immunologic response. 
The total results were not as good as those which were produced by 
the use of the serum vaccine. 
DISCUSSION. 
The experiments reported in the present paper are concerned mainly 
with (1)  the character of the pneumococcus antigen as a factor in the 
antibody response, (2) the onset and rate of development of immunity 
to the pneumococcus. 
As reviewed in the early part of this paper,  some observers have 
found the intact bacterial cell necessary for the development of type- 
specific immunity, whereas others  have  reported  that  solutions  or 
extracts of the pneumococcus are adequate for this purpose.  We have 
employed four  antigens,  two  of them  consisting of the  intact  cell, 
namely, the serum vaccine and the washed bacteria vaccine; and two 
of them  containing water-soluble substances  derived from the  cell, 
namely, a Berkefeld filtrate of the shaken bacteria and a filtrate of the 
broth  culture.  The latter  antigens  are  contained in  a  clear water 
solution free from formed elements. 
Mice were actively immunized by a single intraperitoneal injection 
of each antigen.  On the 3th day after the injection a high grade type- 
specific immunity was demonstrated in all.  Survival of the mlce to a 
virulent culture of the homologous organism was not deemed sufficient ALVAN  L.  BARACH  i01 
to  prove  type-specific immunity, for it  appeared possible that  the 
increased resistance might be due to augmenting the natural defensive 
mechanisms or to the stimulation of the common protein antibody. 
Tillett  (26)  in this  connection found that  immunization of rabbits 
with Type I or Type II pneumococci, and with R forms derived from 
any of the fixed types, was equally effective in producing active im- 
munity against  Type  III  infection.  All  the  mice, therefore, that 
survived injection of Type II culture after previous vaccination with 
Type II antigen were injected with virulent Type I  culture.  None 
survived.  Wright  (27)  was  also  unable  to  demonstrate  increased 
resistance to Type I pneumococci by previous injection with heterolo- 
gous organisms. 
After a  single intravenous injection to rabbits of each of the four 
antigens described above, all sera on the 5th day showed type-specific 
protective substance.  The sera which protected mice against Type 
II culture gave no protection against Type I  culture.  Thus, in both 
active and passive immunity experiments a Berkfeld filtrate contain- 
ing  a  watery extract of  the  pneumococcus cell resulted  in  a  type- 
specific antibody response. 
The  onset  of  definite  type-specific  immunity,  both  active  and 
passive, appeared on the 3rd day after injection of the serum vaccine. 
It increased progressively to the 5th day and remained approximately 
unchanged to the  7th day or longer.  The washed bacteria vaccine 
resulted in a  similar slightly less marked response.  The immunity 
resulting from the filtrate of the shaken bacteria and the broth fil- 
trate began on the 4th day after injection, increased on the 5th, and 
remained stationery from the  5th  to  the  7th day.  The degree of 
active immunity secured on the 5th day from Pneumococcus Type II 
vaccine was  approximately that  which protected a  mouse from an 
intraperitoneal injection of 0.001  cc. of a  culture with a  virulence of 
10-6 cc.  In the case of Type I vaccine protection was obtained against 
0.001 cc. culture with a virulence of 10-7 cc.  The degree of antibody 
response cannot be measured accurately solely by recording su~cival 
after  injection of varying doses of test  culture,  for as  pointed out 
earlier in the paper and as observed by  Neill and Gaspari, the inci- 
dence of  infection between the range  10-3  and  10-6  is not  wholly 
dependent upon dilution.  We  have  considered as of  almost'equal 102  P~Etr~OCOCCUS VACCINE.  I 
importance the total number of animals surviving of the entire group 
(10-3 to 10-6) irrespective of the dose administered.  Lastly, varying 
the virulence of the organism was  of especial help in determining the 
graded  increase  of  early  immunity.  When  active  immunity was 
tested against a Pneumococcus Type II organism of moderately high 
virulence, (10-6), well marked specific immunity appeared on the 3rd 
day.  With an organism of still higher virulence (10-7)  an immune 
response was noted on the 4th day.  In two instances, when a  test 
culture of low virulence was employed, evidence of active immunity 
appeared on the 2nd day.  (Test culture was fatal to a mouse, 10-5 
cc.  in  130  hours.)  In  the  case  of  Type  I  pneumococcus vaccine, 
active immunity appears on the 3rd day even against a highly virulent 
10-7 organism. 
By evaluating these three criteria of resistance, we feel justified in 
stating that an antigen derived from the intact cell gives rise to a type- 
specific immunity both active and passive beginning definitely on the 
3rd day, increasing to the 5th, and remaining approximately station- 
ery to the 7th or longer.  The antigen contained in the filtrate, free 
from formed elements, initiates a  type-specific immunity on the 4th 
day, increases markedly to the 5th, and remains approximately sta- 
tionery to  the  7th day.  The immunity produced by Pneumococcus 
Type I  vaccine is greater than that produced by Type II.  On the 
3rd day, mice vaccinated with Type I  vaccine resisted 100,000 mini- 
mal lethal doses, whereas mice immunized  with Type II resisted 10,000 
minimal lethal doses.  On the 5th day, a  larger percentage of mice 
survived these doses than on the 3rd day. 
We are unable at this time to evaluate the factors which are responsi- 
ble for the early induction of immunity to the pneumococcus.  In the 
preparation of our vaccine we have employed highly virulent cultures, 
relatively short incubation periods, and the addition of human serum 
to  the broth.  The final vaccine was  cleared of broth by carefully 
rinsing the centrifuge tube containing the sedimented bacteria instead 
of washing,  since the washings contained considerable highly anti- 
genic material.  The  average  dose  of  vaccine  administered to  the 
rabbit was 2 to 5 billion organisms intravenously; to the mouse 200 
to 400 million organisms intraperitoneally. 
This study was undertaken with the object of determining whether ALVAN  L.  BARnCE  103 
an active immunity to the pneumococcus could be established in a 
su/ficiently short space of time as to make the injection of vaccine a 
therapeutic possibility in lobar pneumonia.  As far as the time inter- 
val is concerned, our results  support this hypothesis.  Whether  the 
patient with lobar pneumonia would react  as  experimental normal 
animals do raises a question not within the scope of this paper. 
CONCLUSIONS. 
i. The  antigenic  function  of  a  pneumococcus  vaccine  made  from  the 
intact cell was compared with that derived fron a watery extract  of 
the cell free from formed elements.  In each instance, the immunity 
produced was dependent upon type-specific protective substance and 
not upon the elaboration of the common protein antibody. 
2.  The vaccine made from the intact cell resulted in both active and 
passive immunity which began on the 3rd day, increased markedly to 
the 5th, and remained approximately stationery to the 7th day.  In 
the case of the Berkefeld filtrate of the shaken bacteria and the filtrate 
of the broth culture, the immunity began on the 4th day, increased to 
the 5th, and remained approximately stationery to the 7th day.  The 
immunity produced by Pneumococcus Type I vaccine is greater than 
that produced by Type II.  On the 3rd day,  mice vaccinated with 
Type I  vaccine resisted  100,000  minimal lethal doses, whereas mice 
immunized with Type II resisted 10,000 minimal lethal doses.  On the 
5th day, a larger percentage of mice survived these doses than on the 
3rd day. 
3.  Certain  factors  related  to  the preparation  and  dosage of the 
vaccine are discussed. 
4.  As far as the time interval and the degree of immunity produced 
are concerned, these results suggest the possibility of employing pneu- 
mococcus vaccine in suitable doses in the treatment of lobar pneu- 
monia.  That an earlier activity of the immunity mechanism could 
actually be initiated in a  patient with lobar pneumonia has still to 
be demonstrated, 
I wish to express my indebtedness to Dr. A. R. Dochez for his many 
valuable suggestions during the course of the investigation. 104  PNEUMOCOCCUS VACCINE.  I 
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